State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, Ages 50+

Sorted by Rate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 64.3 with a 95% confidence interval from 64.1 to 64.5 and 75,131 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Puerto Rico²

• Rate : The incidence rate is 14.5 with a 95% confidence interval from 14.0 to 14.9 and 754 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 49.9 with a 95% confidence interval from 47.7 to 52.2 and 403 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (48, 51)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 51.5 with a 95% confidence interval from 50.3 to 52.8 and 1,320 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (47, 51)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 52.1 with a 95% confidence interval from 48.1 to 56.2 and 138 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (41, 51)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 53.3 with a 95% confidence interval from 51.0 to 55.7 and 419 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (43, 51)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 55.0 with a 95% confidence interval from 53.2 to 56.8 and 761 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (41, 49)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 55.4 with a 95% confidence interval from 50.7 to 60.5 and 103 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (29, 51)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 55.4 with a 95% confidence interval from 54.8 to 56.0 and 7,131 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (42, 48)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 55.8 with a 95% confidence interval from 54.5 to 57.1 and 1,484 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (41, 48)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 56.5 with a 95% confidence interval from 54.9 to 58.1 and 1,038 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (39, 48)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 57.7 with a 95% confidence interval from 56.0 to 59.5 and 888 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (35, 46)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 58.5 with a 95% confidence interval from 55.2 to 61.9 and 242 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (28, 48)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 59.1 with a 95% confidence interval from 56.3 to 62.0 and 352 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (28, 47)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 59.4 with a 95% confidence interval from 58.6 to 60.2 and 4,350 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (33, 42)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 59.5 with a 95% confidence interval from 58.3 to 60.8 and 1,770 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (32, 42)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 59.9 with a 95% confidence interval from 58.5 to 61.2 and 1,534 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (31, 42)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 59.9 with a 95% confidence interval from 56.5 to 63.5 and 236 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (23, 47)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 60.0 with a 95% confidence interval from 57.9 to 62.2 and 642 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (29, 43)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 60.3 with a 95% confidence interval from 57.4 to 63.4 and 335 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (24, 44)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 60.8 with a 95% confidence interval from 59.3 to 62.4 and 1,210 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (28, 41)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 61.7 with a 95% confidence interval from 60.2 to 63.2 and 1,332 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (27, 39)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 62.4 with a 95% confidence interval from 60.9 to 64.0 and 1,357 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (24, 37)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 62.5 with a 95% confidence interval from 59.5 to 65.5 and 355 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (20, 42)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 63.1 with a 95% confidence interval from 61.9 to 64.2 and 2,368 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (24, 33)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 63.4 with a 95% confidence interval from 61.8 to 65.1 and 1,174 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (22, 34)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 64.2 with a 95% confidence interval from 63.4 to 64.9 and 5,854 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (22, 30)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 64.6 with a 95% confidence interval from 63.5 to 65.8 and 2,393 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (20, 30)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 64.6 with a 95% confidence interval from 61.8 to 67.6 and 402 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (16, 35)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 65.1 with a 95% confidence interval from 63.5 to 66.8 and 1,260 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (19, 30)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 66.0 with a 95% confidence interval from 63.2 to 68.9 and 439 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (13, 32)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 66.1 with a 95% confidence interval from 64.8 to 67.3 and 2,222 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (18, 27)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 66.6 with a 95% confidence interval from 63.0 to 70.2 and 280 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (9, 33)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 67.3 with a 95% confidence interval from 65.2 to 69.5 and 784 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (13, 26)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 68.1 with a 95% confidence interval from 63.0 to 73.4 and 140 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (5, 35)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 68.5 with a 95% confidence interval from 67.5 to 69.5 and 3,496 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (13, 21)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 68.5 with a 95% confidence interval from 64.0 to 73.3 and 178 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (5, 32)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 69.0 with a 95% confidence interval from 68.2 to 69.8 and 5,915 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (12, 20)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 69.1 with a 95% confidence interval from 67.9 to 70.4 and 2,387 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (11, 21)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 69.8 with a 95% confidence interval from 68.7 to 70.9 and 3,049 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (10, 19)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 70.0 with a 95% confidence interval from 68.0 to 72.0 and 941 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (8, 21)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 71.4 with a 95% confidence interval from 69.9 to 72.9 and 1,751 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (7, 16)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 71.5 with a 95% confidence interval from 69.1 to 73.9 and 719 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (5, 19)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 72.2 with a 95% confidence interval from 71.0 to 73.3 and 3,214 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (7, 14)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 73.0 with a 95% confidence interval from 71.5 to 74.6 and 1,718 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (5, 13)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 73.2 with a 95% confidence interval from 69.0 to 77.7 and 233 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (3, 21)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 74.6 with a 95% confidence interval from 72.9 to 76.2 and 1,678 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (4, 11)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 75.2 with a 95% confidence interval from 69.7 to 81.0 and 158 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (2, 20)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 75.4 with a 95% confidence interval from 73.4 to 77.3 and 1,206 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (3, 10)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 76.2 with a 95% confidence interval from 73.9 to 78.6 and 831 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (3, 9)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 78.8 with a 95% confidence interval from 76.8 to 80.8 and 1,270 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (2, 6)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 81.4 with a 95% confidence interval from 78.5 to 84.4 and 605 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 4)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 86.2 with a 95% confidence interval from 83.7 to 88.8 and 904 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 2)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 1:45 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.